The antimicrobial textile market is at a critical juncture as its testing standard system undergoes a major overhaul. A national standard series, 'Evaluation of Antimicrobial Performance of Textiles,' which has been in place for nearly two decades, is being comprehensively revised. Part 3 (shaking flask method) has completed revision and entered the approval stage, while Part 2 (absorption method) recently passed a review meeting in Zhejiang. This signals a systematic upgrade of the entire evaluation framework, with profound implications for manufacturers of underwear, socks, home textiles, sportswear, and medical textiles that heavily rely on antimicrobial claims.
Background of the Revision
The timeline reveals an accelerated pace. The GB/T 20944 series consists of three parts: Part 1 (agar plate diffusion method) published in 2007, Part 2 (absorption method) also in 2007, and Part 3 (shaking flask method) in 2008. Over the past two decades, these standards have provided technical support for the industry. However, with the emergence of new antimicrobial materials and advanced testing technologies, the original methods and scopes have become outdated.
The revision is being carried out in phases rather than simultaneously. Part 3's revision task was assigned in June 2024 (project number 20241952-T-608), and it has now been completed and is awaiting approval, set to fully replace GB/T 20944.3-2008. Part 2's revision task was assigned in June 2025 (project number 20251603-T-608), and the Zhejiang review marks significant progress; once published, it will fully replace GB/T 20944.2-2007. Notably, Part 1 has not yet been included in this round, possibly indicating that its technical route remains accepted or will be addressed separately later.
Industrial Impact
The direct impact lies in the credibility of test results. Over the past two decades, many enterprises have used the absorption method, but it may show deviations when dealing with novel antimicrobial agents such as nanomaterials or photocatalytic materials. The revised standards will adopt test methods that better reflect real-world usage, enhancing accuracy and reliability—but also potentially rendering some existing test reports obsolete, requiring retesting. For buyers, this is beneficial as it reduces the risk of exaggerated claims and brings antimicrobial functionality back to verifiable technical indicators.
The revision will ripple across the supply chain. Upstream suppliers of antimicrobial masterbatches and yarns must ensure their products pass the new tests, or they risk losing downstream orders. Midstream fabric and garment manufacturers will need to reassess product development, adjust finishing processes, and budget for retesting. Downstream brands and retailers will face stricter compliance when labeling products as 'antibacterial.' In the medical textile sector, where antimicrobial performance is essential, products failing to meet the new standards may be excluded from hospital procurement lists.
A deeper effect is on market competition. The antimicrobial textile market has long suffered from concept hype and exaggerated claims. The revised standards provide a unified technical language, allowing genuinely effective products to stand out while raising entry barriers. This may lead to the exit of some technologically weak SMEs, while R&D-capable companies gain larger market shares. For exporters, if the new national standards align more closely with international ones such as ISO 20743, it could help reduce technical trade barriers—but in the short term, they must manage compliance costs arising from standard differences.